These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21497980)

  • 21. Developing Peripheral Blood Gene Expression-Based Diagnostic Tests for Coronary Artery Disease: a Review.
    Rhees B; Wingrove JA
    J Cardiovasc Transl Res; 2015 Aug; 8(6):372-80. PubMed ID: 26109386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The KIF6 collapse.
    Topol EJ; Damani SB
    J Am Coll Cardiol; 2010 Nov; 56(19):1564-6. PubMed ID: 20888161
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacodynamic effects during the transition between cangrelor and prasugrel.
    Schneider DJ; Seecheran N; Raza SS; Keating FK; Gogo P
    Coron Artery Dis; 2015 Jan; 26(1):42-8. PubMed ID: 25089928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease.
    Simons N; Isaacs A; Koek GH; Kuč S; Schaper NC; Brouwers MCGJ
    Gastroenterology; 2017 Mar; 152(4):912-913. PubMed ID: 28157516
    [No Abstract]   [Full Text] [Related]  

  • 25. AGER gene -374T>A (rs1800624) polymorphism is not associated with the severity of non-diabetic coronary artery disease in Han Chinese.
    Lu W; Feng B; Liu F; Zhang D; Qian Q; Zhuang S; Qi W; Zhou H
    Clin Chem Lab Med; 2011 Mar; 49(3):547-9. PubMed ID: 21254849
    [No Abstract]   [Full Text] [Related]  

  • 26. Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
    Erlinge D; Gurbel PA; James S; Lindahl TL; Svensson P; Ten Berg JM; Foley DP; Wagner H; Brown PB; Luo J; Zhou C; Moser BA; Jakubowski JA; Small DS; Winters KJ; Angiolillo DJ
    J Am Coll Cardiol; 2013 Aug; 62(7):577-83. PubMed ID: 23747759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of coronary artery disease: fact or fiction?
    Tousoulis D
    Hellenic J Cardiol; 2017; 58(6):393-395. PubMed ID: 29408370
    [No Abstract]   [Full Text] [Related]  

  • 28. Bench-top sequencing and clinical implementation: diagnostics and biomarkers challenges.
    Bechlioulis A; Lianos GD; Naka K; Roukos DH
    Biomark Med; 2014; 8(2):221-4. PubMed ID: 24521017
    [No Abstract]   [Full Text] [Related]  

  • 29. A genome-wide association analysis identifies novel susceptibility loci for coronary arterial lesions in patients with Kawasaki disease.
    Lin MT; Hsu CL; ; Chen PL; Yang WS; Wang JK; Fann CS; Wu MH
    Transl Res; 2013 Jun; 161(6):513-5. PubMed ID: 23454411
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of DNA damage associated with standard or contrast diagnostic echocardiography.
    Gaibazzi N; Marziliano N; Porter TR; Negri G; Demola MA; Reverberi C; Ardissino D
    Int J Cardiol; 2015 Feb; 180():96-9. PubMed ID: 25438226
    [No Abstract]   [Full Text] [Related]  

  • 31. Understanding coronary artery disease using twin studies.
    Mangino M; Spector T
    Heart; 2013 Mar; 99(6):373-5. PubMed ID: 23142714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Genetic Defects on Coronary Atherosclerosis among Turkish Cypriots.
    Conkbayir C; Fahrioglu Yamaci R; Gencer P; Barin B; Yucel G; Yildiz CE; Ugurlucan M; Basak AN
    Heart Surg Forum; 2017 Oct; 20(5):E223-E229. PubMed ID: 29087287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bibliography current world literature.
    Coron Artery Dis; 2011; 22(6):447-9. PubMed ID: 21814049
    [No Abstract]   [Full Text] [Related]  

  • 34. Family history of cardiovascular disease as a risk factor for coronary artery disease in adult offspring.
    Hoseini K; Sadeghian S; Mahmoudian M; Hamidian R; Abbasi A
    Monaldi Arch Chest Dis; 2008 Jun; 70(2):84-7. PubMed ID: 18754276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in P2Y12 Inhibitor Use in Patients Referred for Invasive Evaluation of Coronary Artery Disease in Contemporary US Practice.
    Fan W; Plent S; Prats J; Deliargyris EN
    Am J Cardiol; 2016 May; 117(9):1439-43. PubMed ID: 27001447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease.
    Wallentin L; Varenhorst C; James S; Erlinge D; Braun OO; Jakubowski JA; Sugidachi A; Winters KJ; Siegbahn A
    Eur Heart J; 2008 Jan; 29(1):21-30. PubMed ID: 18055486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
    Franchi F; Rollini F; Aggarwal N; Hu J; Kureti M; Durairaj A; Duarte VE; Cho JR; Been L; Zenni MM; Bass TA; Angiolillo DJ
    Circulation; 2016 Sep; 134(11):780-92. PubMed ID: 27559041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study.
    Jakubowski JA; Angiolillo DJ; Zhou C; Small DS; Moser BA; Ten Berg JM; Brown PB; James S; Winters KJ; Erlinge D
    Thromb Res; 2014 Sep; 134(3):552-7. PubMed ID: 25022828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bibliography-Editors' selection of current world literature.
    Coron Artery Dis; 2011 Nov; 22(7):518-9. PubMed ID: 21968504
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study on microRNA and Chinese medicine syndromes of coronary artery disease].
    Wang J; Yu G
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov; 32(11):1562-5. PubMed ID: 23359987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.